Pfizer pays $60M to settle government allegations of bribing doctors overseas
Pfizer has agreed to pay the federal government $60 million to settle allegations that its employees bribed doctors and other foreign officials in Europe and Asia to win business and boost sales. The Securities and Exchange Commission said Tuesday that Pfizer's overseas subsidiaries made illegal payments to health care workers in China, Italy, Russia, Croatia and other Eastern European countries. As early as 2001, Pfizer sales representatives tried to conceal the bribes by recording them as legitimate business expenses for travel, entertainment and marketing purposes, the agency said.
- Why Is Healthcare Price Transparency So Hard?
- EHR Spending Continues, But Jury Still Out on ROI
- Adverse Events from Insulin Prescribing 'An Epidemic'
- 5 Hot Healthcare Ideas from SXSW
- Use of Locum Tenens Up 22% in One Year
- Care Coordination a Cost-Cutting Quality Driver
- Hospital Groups Strike Back at Hospital Rating Systems
- Payers Detail Strategies That Drive Consumer Satisfaction
- Hospital CEO Turnover Hits Record High
- The Secret to Physician Engagement? It's Not Better Pay